99 related articles for article (PubMed ID: 27097804)
21. The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.
Wang HY; Tang K; Liang TY; Zhang WZ; Li JY; Wang W; Hu HM; Li MY; Wang HQ; He XZ; Zhu ZY; Liu YW; Zhang SZ
J Exp Clin Cancer Res; 2016 May; 35():86. PubMed ID: 27245697
[TBL] [Abstract][Full Text] [Related]
22. Mutational status of IDH1 in uveal melanoma.
Cimino PJ; Kung Y; Warrick JI; Chang SH; Keene CD
Exp Mol Pathol; 2016 Jun; 100(3):476-81. PubMed ID: 27155448
[TBL] [Abstract][Full Text] [Related]
23. Cushing's disease: pathobiology, diagnosis, and management.
Lonser RR; Nieman L; Oldfield EH
J Neurosurg; 2017 Feb; 126(2):404-417. PubMed ID: 27104844
[TBL] [Abstract][Full Text] [Related]
24. Prolactin-Secreting Pituitary Carcinoma with Dural Metastasis: Diagnosis, Treatment, and Future Directions.
Seltzer J; Carmichael JD; Commins D; Liu CS; Omura E; Chang E; Zada G
World Neurosurg; 2016 Jul; 91():676.e23-8. PubMed ID: 27157283
[TBL] [Abstract][Full Text] [Related]
25. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
26. A Benchmark for Preservation of Normal Pituitary Function After Endoscopic Transsphenoidal Surgery for Pituitary Macroadenomas.
Laws ER; Iuliano SL; Cote DJ; Woodmansee W; Hsu L; Cho CH
World Neurosurg; 2016 Jul; 91():371-5. PubMed ID: 27113402
[TBL] [Abstract][Full Text] [Related]
27. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.
Tebani A; Jotanovic J; Hekmati N; Sivertsson Å; Gudjonsson O; Edén Engström B; Wikström J; Uhlèn M; Casar-Borota O; Pontén F
Acta Neuropathol Commun; 2021 Nov; 9(1):181. PubMed ID: 34758873
[TBL] [Abstract][Full Text] [Related]
28. TGFBR3L-An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue.
Sjöstedt E; Kolnes AJ; Olarescu NC; Mitsios N; Hikmet F; Sivertsson Å; Lindskog C; Øystese KAB; Jørgensen AP; Bollerslev J; Casar-Borota O
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396509
[TBL] [Abstract][Full Text] [Related]
29. FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors.
Kolnes AJ; Øystese KAB; Olarescu NC; Ringstad G; Berg-Johnsen J; Casar-Borota O; Bollerslev J; Jørgensen AP
J Clin Endocrinol Metab; 2020 Aug; 105(8):2587-94. PubMed ID: 32421791
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas.
Li N; Zhan X
Front Endocrinol (Lausanne); 2019; 10():690. PubMed ID: 31649621
[TBL] [Abstract][Full Text] [Related]
31. The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours.
Øystese KAB; Berg JP; Normann KR; Zucknick M; Casar-Borota O; Bollerslev J
Endocrine; 2018 Nov; 62(2):351-360. PubMed ID: 30051197
[TBL] [Abstract][Full Text] [Related]
32. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.
Øystese KA; Zucknick M; Casar-Borota O; Ringstad G; Bollerslev J
Endocrine; 2017 Jul; 57(1):35-45. PubMed ID: 28516382
[TBL] [Abstract][Full Text] [Related]
33. Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain Reaction.
Gondim DD; Gener MA; Curless KL; Cohen-Gadol AA; Hattab EM; Cheng L
Appl Immunohistochem Mol Morphol; 2019; 27(10):722-725. PubMed ID: 30358614
[TBL] [Abstract][Full Text] [Related]
34. Molecular Biology of Pituitary Adenomas.
Faltermeier CM; Magill ST; Blevins LS; Aghi MK
Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
[TBL] [Abstract][Full Text] [Related]
35. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.
Hao S; Hong CS; Feng J; Yang C; Chittiboina P; Zhang J; Zhuang Z
J Neurosurg; 2016 Jun; 124(6):1562-7. PubMed ID: 26473790
[TBL] [Abstract][Full Text] [Related]
36. Recent clinical and pathophysiological advances in non-functioning pituitary adenomas.
Korbonits M; Carlsen E
Horm Res; 2009 Apr; 71 Suppl 2():123-30. PubMed ID: 19407508
[TBL] [Abstract][Full Text] [Related]
37. A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas.
Casar-Borota O; Øystese KA; Sundström M; Melchior L; Popovic V
Pituitary; 2016 Aug; 19(4):407-14. PubMed ID: 27097804
[TBL] [Abstract][Full Text] [Related]
38. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV
Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
